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Abstract
Background: Cancer is the third leading cause of death in the United Arab Emirates (UAE); brain cancer ranks 10th
among the cancers, with 2.9% of the primary cancers originating from the nervous system. The epidemiology of
brain cancers has not been explored. The unique population dynamics of UAE make it a fertile ground for analyzing
the epidemiology of brain cancer. In this study, we aim to look at the frequency patterns and distribution of
malignant primary brain tumors in the UAE.
Methods: A cross sectional study was carried out using data obtained from the Tawam Hospital Cancer Registry for
the years 1984–2017. The sample size included 756 diagnosed cases of malignant primary brain tumors in the UAE.
Using SPSS and Excel software, frequencies, mean ages, histological type frequencies, average annual crude
incidence rates and average annual age adjusted incidence rates were analyzed.
Results: The expatriate population had higher percentage of brain tumors (72%) than the locals. The mean age at
diagnosis was 33.48 years (± 21.14 years) with a male to female ratio of 1.69. Diffuse astrocytic and oligodendroglial
tumors were the most commonly diagnosed tumors overall. Older adults had more cases of lymphoma while
embryonal and ependymal tumors were most commonly seen in younger age groups. The overall average annual
crude incidence rate for 2013–2016 for all primary brain tumors was 0.56 per 100,000 population.
Conclusion: This is the first cancer registry study in the UAE that describes histological types of primary brain
tumors based on the WHO 2016 classification of brain tumors and highlights their incidence rates. Through this
study, several patterns of incidence trends for brain tumors in the UAE, according to histological types, sex and age
groups have been recognized. Comparative studies would help identify the influence of potential changes in
lifestyle, environmental or occupational risk factors on primary brain tumors.
Keywords: Brain tumors, Epidemiology, Incidence rate, United Arab Emirates

Background
Primary central nervous system (CNS) tumors include a
complex, diverse group of benign and malignant tumors
originating from the brain and its surrounding structures.
More than 90% of the primary CNS tumors arise in the
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brain, the remainder are observed in the meninges, spinal
cord and cranial nerves [1]. There are more than a hundred
histologic subtypes of primary brain tumors [2]. Primary
brain tumors are relatively rare, particularly in adults; however, they are the second highest cause of cancer mortality
in people under 19 years of age [2]. Primary brain tumors
may range from being benign to aggressive; nevertheless,
even benign tumors are potentially lethal. Malignant brain
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tumors represent 1.4% of all cancers and 2.4% of all cancer
mortality [3].
Brain tumors are somewhat uncommon considering
one individual in 165 will be diagnosed with a brain tumor
in their lifetime [4]. However, trends from 1970s onwards
have shown an increased diagnosis of brain tumors in developed countries, with a world age standardized incidence rate that ranges from 4.3 to 18.6 per 100,000 per
year [2, 5]. Gliomas are the most common histological
type of primary CNS tumors [1]. Increasing incidence of
brain tumors has been attributed to improved ability to
diagnose brain tumors using computerized tomography
scanning and magnetic resonance imaging [2].
Given the difference of incidence rates over geographical
regions, race and sex, there is a need for greater understanding of the environmental etiology and risk factors of
brain tumors [1], particularly those factors that are not
accounted for by variations in reporting, diagnostic
methods and access to health care [4]. In general, the incidence rate of malignant brain tumors is higher in men
compared to women; however, women have a higher
prevalence rate, indicating a possibly better survival rate
among women [4–6]. Other than ionizing radiation, only
a few risk factors have been consistently associated with
brain tumors. Possible risk factors include smoking, alcohol consumption, mobile phone usage, industrial exposures, infectious agents and some rare genetic
associations. Study of distribution over geographic regions
may help in understanding the role of extrinsic factors in
the distribution of brain tumors [1, 4].
Intracranial tumors can be classified in several ways.
The most basic classification would depend on whether
the tumors are primary or metastatic in origin. Primary
intracranial tumors can further be described in accordance
with the region they originate from; such as brain parenchyma, pituitary, pineal region, meninges, or the base of
the skull. However, the World Health Organization
(WHO) classification is considered the most apt for diagnostic purposes [7]. The WHO 2007 classification was
based on histological features only, the more recent 2016
CNS tumor classification aims towards an integrated diagnosis that includes genotypic and phenotypic characteristics alongside microscopic findings [8, 9].
According to the World Bank statistics, the United
Arab Emirates (UAE) had a population of 9.68 million in
the year 2019, which makes up 0.13% of the world population. UAE comprises of seven emirates of which the
most heavily populated emirate is Dubai with 35.7% of
the population, followed by Abu Dhabi 34.7%, Sharjah
16.2%, Ajman 5.8%, Ras al Khaimah 4.1%, Fujairah 2.7%
and Umm al Quwain 0.9% of the total population. Majority of the population falls into the age group of 2554 years, of whom a large part comprises of the expatriates. The median age of the population is 32.6 years with
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a male to female population ratio of 72 %: 28%. The
greatest disparity in ratio of males to females is seen in
the age group 25-54 years where there are 4.83 million
males compared to 1.47 million females, this is mainly
due to a larger number of expatriate male workers. The
expatriate population comprises of 88.52% of the total
UAE population. Indians comprise the majority of the
expatriate population (27.49%), followed by Pakistanis
(12.69%), while the remaining expatriate population
comes primarily from Bangladesh, Philippines, Iran,
Egypt, Nepal, Sri Lanka and China [10, 11].
Cancer is the third leading cause of death in the UAE following diseases of the circulatory system and injuries. The
cancer incidence in 2015 was 54.5 per 100,000 population
[12] with a mortality of about 500 deaths per year [13]. In
the UAE, breast cancer topped the list of malignancies in
2016: 25.3% of cancers originated in the breast. Brain cancer ranked 10th with 2.9% of the primary cancers originating from the nervous system. In males, brain cancer ranked
9th with 3.9% of the malignancies in men originating from
the brain whereas in women, brain cancer ranked 10th,
comprising 2.5% of malignancies in women [12].
Tawam hospital, being the first cancer care facility in
the UAE, became the first cancer referral hospital in the
country in 1983. The first Tumor Registry in the UAE
was compiled in 1983 as a hospital-based Tumor Registry at Tawam Hospital. Later, this registry was developed
as the official UAE National Cancer Registry in 1998.
The reporting of brain tumors is expected to be exhaustive since a Ministerial Decree made notification of cancer cases mandatory in UAE [13]. The data collected by
the registry includes patient’s demographic details,
tumor information, staging information, cancer treatment and follow up. A large majority of roughly 75-80 %
of all cancer cases in the UAE are included in the Al
Tawam cancer registry database as Tawam hospital, beside another hospital in Abu Dhabi, are the only two
government facilities that offer all three forms of cancer
treatment: surgery, radiation and chemotherapy [14–17].
Despite the plethora of data available from the cancer
registry, very few studies explore the epidemiology of
brain cancers in the UAE. There is significant geographical variation in the incidence of brain cancers around
the world. This variation could be reflective of differences in diagnostic abilities and reporting practices;
however, it is imperative that environmental and sociodemographic characteristics be explored to understand
the patterns and risk factors associated with brain cancer. The UAE has unique population dynamics with almost 89% of the population comprising of expatriates
which makes it a fertile ground for analyzing the epidemiology of brain cancer [11]. In this study we aim to
look at the patterns of distribution and frequency of primary brain tumors in the UAE.
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Methods
Study design and sample

A cross sectional study was carried out using secondary
data obtained from the Tawam Hospital Cancer Registry.
For this particular study, data on age, sex, residence, nationality, histological classification and year of diagnosis
was obtained from the years 1984–2017. The analytic
dataset included 756 diagnosed cases of malignant primary brain tumors in the UAE collected following establishment of the registry.
Data analysis

Since data was obtained over a duration of 33 years,
varying data collection protocols in a newly established
registry translated into missing data for several data categories. Depending on the type of data missing, some
analysis was done for the duration of 1984–2017 (756
cases), while some were only done from 2008 to 2017
(379) cases. All cases were coded following the International Classification of Diseases for Oncology, Third
Edition (ICD-O-3). Following data cleaning, tumor
histological codes were matched and grouped under the
categorization highlighted in the WHO 2016 classification and then these groups were used to analyze the
data. Any tumors with missing histologic confirmation
or that were not classified under the ICD-O-3 site codes
were removed from the data. All cases reported were from
patients who had been seen in UAE hospitals and did not
include autopsy diagnosed tumors. Due to the small number of cases, it was not possible to see trends while analyzing each histological type individually. Based on the
diagnosed cases, the investigators identified primary brain
tumors under 13 categories: 1. Diffuse astrocytic and
oligodendroglial tumors (93,803, 93,823, 94,003, 94,013,
94,113, 94,403, 94,423, 94,503, 94,513, 94,603), 2. Other
astrocytic tumors (94,213, 94,203), 3. Ependymal tumors
(93,913, 93,923), 4. Choroid plexus tumors (93903), 5.
Neuronal and mixed neuronal-glial tumors (95053), 6. Embryonal tumors (94,703,94,713, 94,733, 94,743, 94,903, 95,
083), 7. Tumors of cranial and paraspinal nerves (95600),
8. Meningiomas (95,300, 95,303), 9. Mesenchymal, nonmeningiothelial tumors, (91,503,92,203), 10. Melanocytic
tumors (87203), 11. Lymphomas (95,913, 96,803, 96,903,
96,993, 97,143, 96,701, 96,753, 96,843, 96,873), 12. Germ
cell tumors (90,643, 91,003),13. Other cancers (80,003, 92,
503, 95,003, 97,313).
Using SPSS (version 26) and Excel software (version
16.37), counts, frequencies, mean ages, male to female sex
ratios, proportions, rates, and other relevant statistics were
calculated. Average annual crude incidence rates (AAIR)
and 95% confidence intervals (95% CI) were estimated per
100,000 population, based on one-year age groupings.
Population data for calculations was acquired from the
World Bank data and Central Intelligence Fact Sheet [18,
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19]. Several tables were inspired by representations in
CBTRUS statistical report for primary brain and CNS tumors in the US for 2012-2016 [20]. To facilitate international comparison, the AAIR have been age-adjusted to
the 2017 Gulf Cooperation Council (GCC) population
(AIRGCC) and 2000 United States (US) standard population (AIRUS). Direct method of standardization of AAIR
was applied for years 2013-2017.
Ethical approval and ethical considerations

Ethics approval for this study was obtained from the
Tawam Human Research Ethics committee (T-HREC) in
February 2018 (SA/AJ/559). Following ethical approval,
data on primary brain tumors from the cancer registry
was shared with the investigators. A second ethics approval was obtained from Zayed University Research
Ethics Committee (ZU18_56_E). Ethics approval mandated that the ‘Good Clinical Practice’ and ‘Collaborative
Institutional Training Initiative on Social and Behavioral
Research’ was completed by the researchers.
The secondary data received from the cancer registry
did not include the names of patients who had been diagnosed with brain cancers. However, to further ensure anonymity and respect privacy of the patients, the file number
on record was also removed before data was analyzed.
The researchers did not have access to any personal information that could be traced back to identify the patients.

Results
Between 1984 and 2017, 756 cases of brain tumors were
recorded. As the brain tumor cases were collected over a
time period that exceeds three decades, it was expected
to find missing values in some variables. Nationality and
place of residence (i.e. Emirates) had some missing
values. To overcome bias in data reporting, the frequency distribution for these two variables was limited
to the time period of (2008-2017).
The expatriate population had higher percentage of
brain tumors (72%) than the locals (Table 1). This distribution is consistent with the UAE demography, as local
UAE nationals make up around 20% of the population
according to the most recently available data [21]. However, the average annual incidence rate (per 100,000) of
primary brain tumors was higher among UAE local
population compared to expatriates (1.07: 0.35).
It was observed that majority of the patients diagnosed
with malignant brain tumors were given first course of
treatment in the UAE. Of those who were provided
treatment within UAE, the majority were expatriate
population (Tables 2 and 3) [10].
Regarding the distribution of brain tumors by Emirates, almost half of the brain tumor cases (46.4%) were
living in Abu Dhabi, the capital of the UAE. In Dubai,
the most populous city in the UAE, 18.4% of brain
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Table 1 Distribution of ten- year total, annual average total and average annual incidence rate (AAIR) of brain tumors by nationality,
UAE, 2008–2017
Nationality

Annual average a

Ten-year total (%)

AAIR per 100,000

95% CI

UAE

106 (28.0)

11

1.07

0.81 to 1.33

Expatriates

273 (72.0)

27

0.35

0.3 to 0.4

Total

379 (100.0).

38

a. Annual average cases are calculated by dividing the ten-year total by 10

tumor cases resided. Moving further towards the North
of the capital, one can notice a decreasing trend in the
rate of occurrence of brain tumors (Table 4). This decreasing trend matches the UAE population density as
around 70% of the population reside in Abu Dhabi and
Dubai [10].
The crude incidence rate (CIR) in Abu Dhabi increased from 2005 to 2015, however decreased in Dubai
and Ras Al Khaimah (Table 4).
The mean age at diagnosis was 33.48 years (± 21.14
years) and 201 patients (27.0%) were under 15 years of
age when they were initially diagnosed. Most cases
(46.7%) were in the age group of 25-54 years when diagnosed (Table 5).
For the period (2008 – 2017), the highest annual crude
incidence rate was reported for the year 2008. There is
an overall decreasing trend in the annual CIR over the
years (Table 6). The average annual CIR of brain tumors
for the period 2008 – 2017 was 0.72 per 100,000 (95%
CI: 0.60 to 0.86). A higher CIR in males as compared to
females was seen only in 2010 and 2012.
Overall, high-grade tumors (WHO III/IV) constituted
48.1% (39.3 and 8.8%, respectively) of all cases while the
rest were low grade tumors (WHO I/II) (4.1 and 11.8%
respectively).
Figure 1 shows tumor distribution according to the
histological classification group. Diffuse astrocytic and
oligodendroglia accounted for 64.4% and embryonal tumors constituted 13.1% of the cases.
Figure 2 depicts the sites involved in the brain. More
than 15 % of the tumors were located in the frontal lobe
Table 2 Distribution of brain tumor cases by location of first
course treatment (surgery, radiotherapy, and chemotherapy),
UAE, 2008-2017
First Course
Treatment Location
Surgery
n (%)

Radiation
n (%)

Chemotherapy
n (%)

Inside UAE

58 (49.2%)

65 (55.1%)

55 (46.6%)

Outside UAE

40 (33.9%)

20 (16.9%)

13 (11%)

Combination

0%

0%

8 (6.8%)

and another 10% were in the parietal lobe; around 25%
(187 cases) involved overlapping lesions in the brain.
There were more male cases than females for most
histological types, the highest being recorded for diffused
astrocytic and oligodendroglial tumors (321 males vs 162
females). In addition, ependymal tumors occurred equally
among both genders. Meningiomas and lymphomas were
seen more commonly in older adults (mean age at diagnosis 48.0 and 49.5 years respectively) while the younger
population saw more cases of embryonal and ependymal
tumors (mean age at diagnosis 11.30 and 18.87 years respectively). The mean age distribution for males and females by histological type were almost similar for all types
except for germ cell tumor and embryonal tumors. Females had germ cell tumors at an older age (mean age
33.50 years, ± 33.63 years) as compared to males (mean
age at diagnosis 18.78 years, ± 24.74 years). A significant
difference was found between the mean age distribution
of males and females for embryonal tumors. Embryonal
tumors occurred among males at an older age (mean age
13.2 years, ± 12.31 years) as compared to females (mean
age at diagnosis 8.8 years, ± 7.83 years) (Table 7).
There were 161 incident primary brain tumor cases recorded in the registry during the period 2013-2017. The
overall average annual crude incidence rate for 2013–
2016 for all primary brain tumors was 0.56 per 100,000
population (Table 8). When standardized to the 2000 US
standard population, the overall average annual incidence rate was 1.19 per 100,000 population. When standardized to the 2017 GCC population, the overall
average annual incidence rate was 0.67 per 100,000
population. The average annual crude incidence rate was
0.69 per 100,000 for children aged 0-14 years, 0.33 per
100,000 population for those aged 15-24 years, 0.43 per
100,000 population for adults aged 25-54 years, 1.63 per
Table 3 Distribution of treatment location (surgery,
radiotherapy and chemotherapy) by nationality of brain tumor
cases, UAE, 2008-2017
UAE
N (%)

Expat
N (%)

p-value

Surgery within UAE

7 (12.1)

51 (87.9)

0.014

No treatment

20 (16.9%)

33 (27.9%)

42 (35.6%)

Radiotherapy within UAE

5 (7.7)

60 (92.3)

0.000

Total

118 (100%)

118 (100%)

118 (100%)

Chemotherapy within UAE

7 (7.3)

51 (92.7)

0.001
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Table 4 Ten-year total, annual average total a, and annual crude
incidence rates (CIR)b per 100,000 of brain tumors by Emirates, UAE
Period of inclusion: 2008-2017
Emirate

Ten-year Annual
total
average

% of all
tumors

CIR CIR
2005 2015

Abu Dhabi

134

13

46.4%

0.36

0.83

Dubai

55

5

18.4%

0.76

0.12

Sharjah

58

6

19.4%

0.63

0.64

Ras Al Khaimah

16

2

5.3%

1.99

0.68

Ajman

21

2

7.0%

0.48

0.00

Fujairah

9

1

3.0%

0.00

0.47

Umm Al Quwain 6

1

2.0%

0.00

0.00

30

100%

0.54

0.42

c

Total

299

a

: Annual average cases are calculated by dividing the total by ten.
b
: CIR is calculated for years 2005 and 2015.
c
: Excludes cases from outside UAE.

100,000 population for those aged 55-64 years, and 5.23
per 100,000 population for those over 65 years of age.
Those aged 15-24 years had the lowest average annual
age-adjusted incidence rates (both AIRGCC and AIRUS).
The highest average annual age-adjusted incidence rate
was reported for those over 65 years of age. Age-adjusted
incidence rates of embryonal and ependymal tumors were
highest among children while age-adjusted incidence rates
of diffuse astrocytic and oligodendroglial tumors were
highest among those over 65 years of age (Table 8).

Discussion
The overall incidence of brain tumors worldwide has
been reported to be increasing in the last few decades.
This increase has been attributed mainly to better diagnostic and imaging techniques [22, 23]. While generally,
there is an increase in diagnosis of malignant brain tumors in UAE, the increase in cases recorded does not
show a consistently upward trend as indicated in other
studies [22–24]. In this study the number of cases diagnosed, and the crude incidence rate peaked in 2008 (48
cases, 1.04 per 100,000) after which the cases have declined comparatively. This increase in 2008 could possibly be due to the rapid influx of expatriates resulting in
Table 5 Distribution of Brain Tumors by Age at Diagnosis, UAE,
1984–2017
Age at Diagnosis

n (%)

0-14

201 (27.0)

15-24

60 (8.1)

25-54

348 (46.7)

55-64

80 (10.6)

65+

56 (7.5)

Total

745 (100.0)

Mean Age at Diagnosis: 33.48 years (± 21.14 years).

a higher percentage of population growth in the UAE
during this time period [11]. It is noticeable that the incidence of primary brain tumors in Abu Dhabi increased
from 2005 to 2015 whereas it decreased in Dubai and
Ras Al Khaimah. This could be explained by the establishment of the Dubai Hospital Tumor Registry in 2014,
which may have diverted or delayed reporting of some
cases at the Tawam Hospital Cancer Registry in Abu
Dhabi [17]. The highest percentage of brain tumors were
diagnosed at grade IV differentiation, which is reinforced
further by the finding of a high number of gliomas recorded in the registry. Health insurance became
mandatory for all residents of UAE thus healthcare services became affordable to all, which could also explain
the higher number of confirmed cases diagnosed over
time. With healthcare insurance for all, the likelihood of
cases going undiagnosed may have decreased. The availability of good quality healthcare to all residents also explains why a large number of expatriates have sought
first course of treatment within the UAE rather than
other countries [25].
The mean age at diagnosis of malignant brain tumors
in this study was 33.48 years. Weeks (2016) reported the
median age of diagnosis of all brain tumors to be at 59
years in the USA [24] while Ostrom et al. (2019) reported the median age of diagnosis of all primary brain
tumors and all other CNS tumors to be at 60 years [20].
Darlix et al. (2016) reported a mean age at diagnosis of
52.6 years, 51.9 for males and 53.3 years for females in
France [26], while Tamimi et al. (2016) in a study carried
out in Jordan reported a mean age of diagnosis of 39.2
years. The mean age of diagnosis in Jordan is comparable to the findings in the UAE, indicating similarities
which could be associated with socio-geographical similarities [23]. The mean age of diagnosis needs to take in
to account the consideration that this study included
only malignant primary brain tumors and not all primary brain tumors. Looking at population pyramid
structures of Jordan, UAE and France we could possibly
attribute the lower median age of diagnosis of malignant
brain tumors to the comparatively greater percentage of
population in the 24-54-year age group in UAE. This inflated population group is mainly due to the presence of
expatriate population, predominantly male expatriates,
who have also been recorded as having a seemingly
higher number of diagnosed malignant brain tumors
compared to the local UAE population (Table 1). Jordan
does not show a similar increase in population in the
middle age year groups but shows a heavier dominance
of younger population, which could be an explanation
for more tumors being diagnosed at a younger age. On
the contrary, France shows a stable to aging population
with the greatest dominance of people in the 45-79-year
age group, possibly explaining why median age of
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Table 6 Crude Incidence Rate (CIR) of primary brain tumor cases by sex and year of diagnosis, UAE, 2008 – 2017
Year

Number of Male
Cases

Number of Female
Cases

Total Number of
Cases

Male CIR per Female CIR Male CIR /Female
100,000
per 100,000 CIR

Total CIR
per 100,000

2008

29

19

48

0.91

1.31

0.70

1.04

2009

28

16

44

0.85

1.07

0.80

0.92

2010

28

11

39

0.85

0.73

1.16

0.81

2011

25

20

45

0.71

1.24

0.57

0.87

2012

31

8

39

0.85

0.48

1.77

0.73

2013

22

13

35

0.59

0.76

0.77

0.64

2014

21

12

33

0.54

0.68

0.80

0.59

2015

22

17

39

0.56

0.94

0.59

0.67

2016

22

11

33

0.54

0.59

0.92

0.56

2017

13

11

24

0.31

0.57

0.54

0.40

Total

241

138

379

6.71

8.37

0.80

7.23

Annual
Averagea

24

14

38

0.67

0.84

0.80

0.72

[0.53, 0.81]

[0.63-1.04]

95% CI
a

[0.60-0.86]

Annual Average is calculated by dividing the total by ten.

diagnosis is higher. These features of the population distributions in various countries may offer some hints into
explaining the varying mean age of diagnosis across different countries [11, 27, 28].
In the UAE, more males were diagnosed with malignant brain tumors with a male to female ratio of 1.69, a
total of 467 (62.76%) males and 277 (37.24%) females.
Darlix et al. (2016) reported a male to female ratio of
0.86 in France [26] and Tamimi et al. (2016) also reported a higher male to female ratio of malignant tumors in Jordan. Generally, a higher male to female

Fig. 1 Distribution of brain tumors by histological type, UAE, 1984–2017

incidence rate ratio for malignant brain tumors is observed in several studies showing international comparisons [4, 6]. However, in this study despite seeing higher
number of males being diagnosed with malignant brain
tumors, on comparing the CIR of men and women it
was seen that women have a higher annual average CIR
(0.84 per 100,000) compared to men (0.67 per 100,000).
The UAE has a much higher male population (69.12%)
compared to women (30.88%) explaining the overall
higher number of malignant brain tumors in males.
However, Jordan and France both have almost equal
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Fig. 2 Distribution of brain tumors by tissue of origin, UAE, 1984–2017. (‘Others’ include CNS not otherwise specified, Tentorium not otherwise
specified, Cerebral meninges, Dura not otherwise specified)

Glioma and meningioma were the most common tumors seen in adults in Sweden [6]. Jazayeri et al. (2013)
highlighted astrocytomas and glioblastomas as being the
most frequent malignant brain tumor in adults in Iran.
It was also noticed that even though males had more
malignant brain tumors, meningiomas were more common in females [29]. Interestingly, Jordan showed meningioma as the most frequently found tumor followed by
glioblastoma and astrocytoma. Meningiomas were seen
to be the most frequent malignant tumors in Jordan,
United States, France and Korea. Once again meningiomas were most frequent in females while astrocytomas
were most common in males [23, 30]. This female

gender distributions and the dominance of male to female ratio of diagnosis cannot be rationalized on the
basis of population distributions [11, 27, 28].
Bondy et al. (2008) highlighted medulloblastoma (embryonal category) and gliomas (diffuse astrocytic and
oligodendroglial category) as the most common types of
pediatric tumors (less than 15 years) in Sweden. Ostrom
et al. (2019) reported that the incidence rates of astrocytoma, germ cell tumors and embryonal tumors were
higher in younger age group and decreased with advancing age. This study in the UAE also showed a predominance of embryonal and diffuse astrocytoma and
oligodendroglial tumors in the pediatric age group.

Table 7 Case distribution by histological type, with the number of cases, sex ratio, and mean ages at diagnosis by gender, UAE,
1984-2017a
Histology

n (%)

Male,n

Female, n

Sex Ratio

Mean ages

Mean
age,
(±SD)
male

Mean
age,
(±SD)
female

Diffuse astrocytic and oligodendroglial tumors

483(65%)

321

162

1.98

38.5

39.95 (±18.86)

37.60 (±19.75)

Other astrocytic

31(4%)

16

15

1.07

20.8

22.44 (±18.12)

19.13 (±15.87)

Ependymal

46(6%)

23

23

1.00

18.87

18.56 (±21.95)

19.17 (±18.64)

Embryonal*

97(13%)

55

42

1.31

11.30

13.20 (±12.31)

8.81 (±7.83)

Meningioma

31(4%)

17

14

1.2

48.03

50.06 (±12.60)

45.57 (±19.59)

Lymphoma

33(4%)

20

13

1.54

49.45

50.30 (±15.09)

48.15 (±12.08)

Germ cell tumors

13(2%)

9

4

2.25

23.31

18.78 (±24.74)

33.50 (±33.63)

Totalb

744

467

277

1.69

33.48 (±21.14)

34.77 (±20.83)

31.31 (±21.52)

*: p < 0.05
a
. Categories with fewer than 5 cases reported are not presented.
b
. Refers to all brain tumors including types not presented in this table.
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Table 8 Five-year total, average annual crude incidence rate with 95% confidence intervals by histological type, and average annual
age-adjusted incidence ratesa with 95% confidence intervals, for all primary brain tumors, UAE, 2013-2017
Age at Diagnosis (0-14 Years)
95% CI

AIRGCC

AIRUS

Histology

5-Year Total

IR

Diffuse astrocytic & oligodendroglial

14

0.24

[0.10, 0.38]

Other astrocytic

2

0.03

[-0.01, 0.07]

–

Ependymal

7

0.12

[0.05, 0.19]

0.02

Embryonal

17

0.29

[0.13, 0.44]

0.05

[0.024, 0.08]

0.06

[0.03, 0.09]

Germ cell tumors

1

0.02

[-0.01, 0.05]

–

–

–

–

Subtotal

41

0.69

[0.34, 1.04]

0.13

[0.06, 0.19]

0.15

[0.07, 0.22]

0.04

95% CI
[0.018, 0.07]

95% CI

0.05

[0.028, 0.08]

–

–

–

[0.01, 0.03]

0.02

[0.002, 0.04]

Age at Diagnosis (15-24)
Histology

5-Year Total

IR

95% CI

AIRGCC

95% CI

AIRUS

95% CI

Diffuse astrocytic & oligodendroglial

8

0.2

[0.08, 0.30]

0.04

[0.01, 0.07]

0.03

[0.01, 0.05]

Other astrocytic

2

0.05

[-0.001, 0.11]

–

–

–

–

Choroid plexus tumors

1

0.03

[-0.02, 0.08]

–

–

–

–

Embryonal

1

0.03

[-0.02, 0.08]

–

–

–

–

Meningiomas

1

0.02

[-0.03, 0.07]

–

–

–

–

Subtotal

13

0.33

[0.09, 0.57]

0.06

[0.02, 0.11]

0.05

[0.01, 0.08]

Age at Diagnosis (25-54)
Histology

5-Year Total

IR

95% CI

AIRGCC

95% CI

AIRUS

95% CI

Diffuse astrocytic & oligodendroglial

64

0.36

[0.29, 0.43]

0.2

[0.17, 0.23]

0.16

[0.13, 0.19]

Other astrocytic

1

0.006

[-0.005, 0.17]

–

–

–

–

Ependymal

3

0.02

[-0.001, 0.041]

–

–

–

–

Embryonal

4

0.02

[-0.001, 0.041]

–

–

–

–

Lymphomas

4

0.02

[-0.001, 0.041]

–

–

–

–

Germ cell tumors

1

0.006

[-0.005, 0.017]

–

–

–

–

Subtotal

77

0.43

[0.3, 0,57]

0.24

[0.16, 0.31]

0.19

[0.13, 0.25]

Histology

5-Year Total

IR

95% CI

AIRGCC

95% CI

AIRUS

95% CI

Diffuse astrocytic & oligodendroglial

14

1.5

[0.45,2.55]

0.08

[0.03, 0.13]

0.13

[0.04, 0.22]

Lymphomas

1

0.1

[-0.10, 0.30]

–

–

–

–

Subtotal

15

1.63

[0.26, 3.00]

0.08

[0.01, 0.15]

0.14

[0.02, 0.26]

Age at Diagnosis (55-64)

Age at Diagnosis (65+ Years)
Histology

5-Year Total

IR

95% CI

AIRGCC

95% CI

AIRUS

95% CI

Diffuse astrocytic & oligodendroglial

14

4.8

[3.26, 6.34]

0.15

[0.1, 0.2]

0.61

[0.41, 0.8]

Lymphomas

1

0.38

[-0.4, 1.12]

–

–

–

–

Subtotal

15

5.23

[2.08, 8.34]

0.16

[0.07, 0.26]

0.66

[0.26, 1.06]

TOTAL

161

0.56

[0.46, 0.66]

0.67

[0.54, 0.81]

1.19

[0.82, 1.56]

a

. Rates are per 100,000 and are age-adjusted to the 2017 GCC population (AIRGCC) and 2000 US standard population (AIRUS)
-- Average annual age-adjusted incidence rates with 95% confidence intervals are not presented when fewer than 5 cases were reported for the specific category
Tumor categories with zero cases per age group were excluded from the above table

predominance of meningiomas has been linked to hormonal influence in women. Greater expression of progesterone receptors in meningiomas may explain increased
frequency in females as compared to males. Similarly,
women seem to have less gliomas during menarche and
menopause as noted by the New York State Cancer Registry [22] .

In this study, meningiomas were not as commonly
seen as in other studies, however this may be due to the
inclusion of only malignant brain tumors in this study.
Tumors under the classification of astrocytic and oligodendroglial tumors were the most frequently found tumors in both males and females. Since gliomas and
astrocytomas were all grouped under this category
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together the numbers may seem exaggerated compared
to other studies. Nevertheless, the trend of gliomas and
astrocytomas being the most commonly found adult
tumor was seen in UAE as in other studies [7]. Malignant meningiomas were much less frequent and
followed after embryonal, ependymal tumors and lymphomas. The total number of meningiomas seen in UAE
was more in males, however this could be explained by
the heavy predominance of the male population in UAE
that could be masking the true comparison. Among
women, the most commonly found tumor was under the
category of diffuse astrocytic and oligodendroglial tumors followed by embryonal tumors, ependymal, meningiomas and lymphomas. In men, a similar trend was
seen; however, lymphomas were more frequent than
meningiomas. Embryonal tumors were found at a significantly older age in males compared to females.
The average annual crude incidence rate in this study
was calculated to be 0.56/100000 and average age adjusted incidence rate calculated in this study was 1.19/
100,000 which is much lower in comparison to the overall incidence of 7.08/100000 reported by CBTRUS and
the range of 2.1-5.8 /100,000 incidence rate of primary
brain tumors observed in various studies [6, 20] . The
calculated incidence rate also appears to be lower than
the age adjusted incidence rate of the New Zealand Cancer Registry and Gironde Cancer Registry (6.7 and 7.4
per 100,000 respectively) [2]. The incidence rate of primary malignant brain tumors in Iran was recorded as
2.74/100000 which is lower than seen in other developed
countries [29]. Age adjusted incidence rates were calculated to make the data comparable to other international
studies exploring epidemiology of malignant brain tumors that typically standardize to the 2000 US standard
population. This study calculated annual average age adjusted incidence rate incidence rate to be 0.67/100000
when adjusted to the GCC standard population. The
GCC population was used to provide comparison with
the local context.
The findings in this study need to be considered in the
light of some strengths and limitations Some weaknesses
and limitations encountered were that the number of tumors diagnosed was low making it necessary to group
the tumors into the WHO main histological categories
to be able to analyze them, rather than performing analysis on each histological subtype. Since the secondary
data was collected over three decades, there is the likelihood that diagnostic procedures and classification criteria may have changed over time, however most
analysis in this study have been conducted from 2008
onwards. Registry studies are considered generalizable
with strong external validity since they include typical
patients representing a heterogeneous population [31].
However, the population in the UAE is so dynamic that
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generalizability should be considered with caution. The
study includes only histologically confirmed cases of malignant brain tumors as listed in the data registry and
may have missed cases that were not diagnosed in the
UAE or not diagnosed at all. There is also the possibility
that some tumors may have been metastatic but reported as primary malignant tumors, as diagnostic and
reporting techniques evolved [32]. However, since only
tumors classified under ICD-O-3 codes were included in
the analysis such erroneous inclusions were most likely
avoided. Due to the dearth of epidemiological studies on
brain tumors in the region, we were unable to compare
the findings of this study to others conducted in similar
sociodemographic settings.
To the best of our knowledge, this is the first-time
data on brain tumors has been reported and analyzed in
the UAE and in the GCC. This study adopts the latest
WHO classification of tumors of the central nervous system and has encompassed data on malignant brain tumors collected over three decades. The data was
provided by the reputed Tawam Cancer Registry and
thus held in high regard in terms of accuracy and rigor
of collection [32]. This study brings together essential
data on descriptive epidemiology of primary malignant
brain tumors which could form the basis for clinical
population-based studies. Also, this study lays the foundation for comparison and benchmarking for future
studies carried out on brain tumors in the region.

Conclusion
This is the first national registry study in the UAE
that describes histological types of primary brain tumors based on the WHO 2016 classification of brain
tumors and highlights their incidence rates. This
study has analyzed more than three decades of data
obtained from the Cancer Registry at Tawam Hospital. Through this study several patterns of incidence
trends for brain tumors in UAE, according to histological types, sex and age groups have been recognized. The incidence rates were standardized to allow
comparability with the US and GCC populations.
These trends suggest a socio-geographical influence
on the incidence of brain tumors. There is a need for
further epidemiological studies of brain tumors in the
region, such comparative studies would help identify
the influence of potential changes in lifestyle, environmental or occupational risk factors on primary brain
tumors.
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